BackMolecular Data Overview

Molecular Data Operating Income

Latest operating income for MKD: $150M.

Get informed when a big investor buys or sells

+ Follow

Quarterly Operating Income

$291.04M
596.7% YoY

As of Dec 31, 2020

Annual Operating Income (TTM)

$150.20M

Trailing 12 months ending Dec 31, 2020

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Molecular Data (MKD) FAQ

Molecular Data posts a operating income of $150M as of December 2020. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

Operating Income is one piece of Molecular Data's financial statement story. At $150M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for MKD's operating income usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Molecular Data's other metric pages and overview cover the third.

Judging Molecular Data against Industrials peers is usually better than using a market-wide rule of thumb. Business models inside Industrials are more comparable, which makes gaps in operating income easier to interpret. Start with $150M here, then scan peer and history charts to see if the gap is persistent.